Literature DB >> 26849474

Synthesis and in Vitro Studies of a Series of Carborane-Containing Boron Dipyrromethenes (BODIPYs).

Sunting Xuan1, Ning Zhao1, Zehua Zhou1, Frank R Fronczek1, M Graça H Vicente1.   

Abstract

A series of seven BODIPYs functionalized with ortho-carborane groups at the 8(meso) or 3/5(α) position were synthesized and characterized by NMR, HRMS, HPLC, and in the cases of 2b and 5b, by X-ray analysis. The BODIPYs exhibited low dark toxicity and phototoxicity toward human glioma T98G cells, and their cellular uptake varied significantly, with 5b accumulating the most and 7 the least. All BODIPYs localized mainly within the cell ER. The BODIPYs showed higher permeabilities than lucifer yellow across human hCMEC/D3 brain endothelial cell monolayers as the BBB model. Among this series, 1b showed the highest BBB permeability (Pe = 16.4 × 10(-5) cm/s), probably as a result of its lower MW (366 Da) and favorable hydrophobicity (log P = 1.5). The combination of low cytotoxicity, amphiphilicity, high boron content, high cellular uptake, and moderate BBB permeability renders these compounds promising boron delivery agents for the BNCT of brain tumors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26849474      PMCID: PMC4893941          DOI: 10.1021/acs.jmedchem.5b01783

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  31 in total

Review 1.  Determinants of passive drug entry into the central nervous system.

Authors:  M D Habgood; D J Begley; N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  Synthesis and properties of a series of carboranyl-BODIPYs.

Authors:  Jaime H Gibbs; Haijun Wang; N V S Dinesh K Bhupathiraju; Frank R Fronczek; Kevin M Smith; M Graça H Vicente
Journal:  J Organomet Chem       Date:  2015-12-01       Impact factor: 2.369

Review 3.  The blood-brain barrier: bottleneck in brain drug development.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 4.  The role of blood-brain barrier permeability in brain tumor imaging and therapeutics.

Authors:  James M Provenzale; Srinivasan Mukundan; Mark Dewhirst
Journal:  AJR Am J Roentgenol       Date:  2005-09       Impact factor: 3.959

Review 5.  The blood-brain barrier in neuroinflammatory diseases.

Authors:  H E de Vries; J Kuiper; A G de Boer; T J Van Berkel; D D Breimer
Journal:  Pharmacol Rev       Date:  1997-06       Impact factor: 25.468

6.  Blood-brain barrier (BBB) toxicity and permeability assessment after L-(4-¹⁰Boronophenyl)alanine, a conventional B-containing drug for boron neutron capture therapy, using an in vitro BBB model.

Authors:  E Roda; S Nion; G Bernocchi; T Coccini
Journal:  Brain Res       Date:  2014-08-13       Impact factor: 3.252

7.  Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential.

Authors:  J W Hopewell; T Gorlia; L Pellettieri; V Giusti; B H-Stenstam; K Sköld
Journal:  Appl Radiat Isot       Date:  2011-03-23       Impact factor: 1.513

Review 8.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

9.  Synthesis of 3,8-dichloro-6-ethyl-1,2,5,7-tetramethyl-BODIPY from an asymmetric dipyrroketone and reactivity studies at the 3,5,8-positions.

Authors:  Ning Zhao; M Graça H Vicente; Frank R Fronczek; Kevin M Smith
Journal:  Chemistry       Date:  2015-03-11       Impact factor: 5.236

10.  The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies.

Authors:  Birk Poller; Heike Gutmann; Stephan Krähenbühl; Babette Weksler; Ignacio Romero; Pierre-Olivier Couraud; Gerald Tuffin; Jürgen Drewe; Jörg Huwyler
Journal:  J Neurochem       Date:  2008-12       Impact factor: 5.372

View more
  8 in total

1.  Synthesis and Spectroscopic Investigation of a Series of Push-Pull Boron Dipyrromethenes (BODIPYs).

Authors:  Sunting Xuan; Ning Zhao; Xiangyi Ke; Zehua Zhou; Frank R Fronczek; Karl M Kadish; Kevin M Smith; M Graça H Vicente
Journal:  J Org Chem       Date:  2017-02-16       Impact factor: 4.354

2.  Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells.

Authors:  Ning Zhao; Tyrslai M Williams; Zehua Zhou; Frank R Fronczek; Martha Sibrian-Vazquez; Seetharama D Jois; M Graça H Vicente
Journal:  Bioconjug Chem       Date:  2017-04-28       Impact factor: 4.774

3.  Enhanced Hypsochromic Shifts, Quantum Yield, and π-π Interactions in a meso,β-Heteroaryl-Fused BODIPY.

Authors:  Ning Zhao; Sunting Xuan; Frank R Fronczek; Kevin M Smith; M Graça H Vicente
Journal:  J Org Chem       Date:  2017-03-10       Impact factor: 4.354

Review 4.  Glioblastoma: Current Status, Emerging Targets, and Recent Advances.

Authors:  Amandeep Thakur; Chetna Faujdar; Ram Sharma; Sachin Sharma; Basant Malik; Kunal Nepali; Jing Ping Liou
Journal:  J Med Chem       Date:  2022-07-05       Impact factor: 8.039

5.  Synthesis and regioselective functionalization of perhalogenated BODIPYs.

Authors:  Ning Zhao; Sunting Xuan; Brandon Byrd; Frank R Fronczek; Kevin M Smith; M Graça H Vicente
Journal:  Org Biomol Chem       Date:  2016-06-02       Impact factor: 3.876

6.  A Comparison of the Photophysical, Electrochemical and Cytotoxic Properties of meso-(2-, 3- and 4-Pyridyl)-BODIPYs and Their Derivatives.

Authors:  Caroline Ndung'u; Daniel J LaMaster; Simran Dhingra; Nathan H Mitchell; Petia Bobadova-Parvanova; Frank R Fronczek; Noémie Elgrishi; Maria da Graça H Vicente
Journal:  Sensors (Basel)       Date:  2022-07-07       Impact factor: 3.847

7.  Quinoline-Conjugated Ruthenacarboranes: Toward Hybrid Drugs with a Dual Mode of Action.

Authors:  Marta Gozzi; Blagoje Murganic; Dijana Drača; John Popp; Peter Coburger; Danijela Maksimović-Ivanić; Sanja Mijatović; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2019-11-19       Impact factor: 3.466

8.  Aza-BODIPY: A New Vector for Enhanced Theranostic Boron Neutron Capture Therapy Applications.

Authors:  Ghadir Kalot; Amélie Godard; Benoît Busser; Jacques Pliquett; Mans Broekgaarden; Vincent Motto-Ros; Karl David Wegner; Ute Resch-Genger; Ulli Köster; Franck Denat; Jean-Luc Coll; Ewen Bodio; Christine Goze; Lucie Sancey
Journal:  Cells       Date:  2020-08-25       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.